About Kronos Bio
Kronos Bio, Inc. is dedicated to the discovery and development of first-in-class therapies that modulate deregulated transcriptional regulatory networks. We leverage deep capabilities in small molecule drug discovery and cancer biology in order to identify potent and selective compounds against transcription factors, transcriptional cofactors and other central drivers of oncogenic signaling.
Summary of Position:
This role will be responsible for providing comprehensive support to end-users, enterprise applications, and both company-owned and personal devices. The role involves assisting internal users, consultants, contractors, CROs, and vendors with onboarding, offboarding, and managing access via security groups. This role will support both onsite and remote users and will work with enterprise applications such as Microsoft Office 365 (Outlook, OneDrive, SharePoint, Teams), Intune, and Jamf, managing a mix of Windows and MacOS environments.
Essential Duties and Responsibilities:
- Supporting desktop applications deployment and remote assistance using tools like TeamViewer.
- Administering and supporting Zoom conferencing solutions.
- Learning and taking ownership of IT processes and procedures.
- Independently prioritizing work, escalating requests as needed, and troubleshooting issues effectively using the OSI model.
- Documenting work performed and referring to documentation for applications and hardware to ensure accurate support.
Additionally, the Specialist will act as a backup for the Infrastructure Operations Director. This includes:
- Gaining a strong understanding of Kronos Bio’s SD-WAN topology, including physical sites and virtual datacenters.
- Working with Cisco Meraki network devices (MX, vMX, MS, MR), and understanding network services like DNS and DHCP.
- Managing network protocols (SSH, SFTP, SMB), and cloud services (AWS, Azure).
- Utilizing Microsoft Entra Id, multi-factor authentication, conditional access policies, and REST APIs.
- Applying security concepts such as zero-trust, defense-in-depth, and principle of least privilege.
- Using scripting skills in Python and PowerShell.
Qualifications:
- Bachelor’s degree in computer science or 6+ years of relevant IT experience in end-user support, networking, and systems administration.
- Azure Administrator certification.
- AWS SysOps certification.
- Cisco Certified Network Associate (CCNA).
- Preferred experience in the biotech or life sciences industry, with an understanding of the unique IT needs and regulatory requirements of this sector.
Skills:
- Apple Devices: Jamf, macOS
- Azure: Microsoft Entra Id, Microsoft Intune
- AWS: SysOps, cloud services
- Networking: Cisco Meraki (MX, vMX, MS, MR), DNS, DHCP, SSH, SFTP, SMB
- Applications: Microsoft Office 365, Microsoft Defender, Microsoft Purview, Zoom (Meetings & Rooms), TeamViewer, Posit Teams
- Backup Solutions: Druva M365 Backup, Code42
- Security: Crowdstrike, ProofPoint email security, security concepts (zero-trust, defense-in-depth, principle of least privilege)
- SaaS Applications: Various integrations
- Hardware: Dell, HP, Lenovo devices
- Virtualization: VMware ESXi, Docker, Kubernetes
- Operating Systems: Windows OS, Ubuntu Server, MacOS
- Print Solutions: PrinterLogic (cloud-based)
- Other Tools: Freshservice, Windows Admin Center, Python, PowerShell, REST APIs, SDKs
Disclaimer:
The above statements are intended to describe the general nature and level of work being performed by employees assigned to this classification. They are not intended to be construed as an exhaustive list of all responsibilities, duties and skills required of employees assigned to this position.
Top Skills
What We Do
Kronos Bio is a clinical-stage biopharmaceutical company developing therapeutics that target the dysregulated transcription that causes cancer and other serious diseases.
Our pipeline includes two investigational oral SYK inhibitors, entospletinib and lanraplenib, which are being developed to treat acute myeloid leukemia (AML). Together the compounds have the potential to target mutations present in more than two-thirds of patients with AML. We are also advancing an oral CDK9 inhibitor, KB-0742, to treat patients with solid tumors addicted to oncogenic transcription factor activity. KB-0742 is the first investigational medicine from our internal discovery platform to enter the clinic. Beyond these three investigational compounds, we are progressing additional discovery programs, including one focused on the MYC TRN and another focused on the AR TRN.
For additional information about our community guidelines, visit: https://bit.ly/3FfcDQW.